Colossal’s GenoMorph AI Finds 2,300 Dodo Gene-Editing Targets
Colossal's GenoMorph AI finds 2,300 dodo gene-editing targets, combining bird genomics and 3D morphology to speed lab validation of de-extinction work.
Summary
Colossal Biosciences unveiled GenoMorph on Wednesday, October 14, 2026, an AI platform using 3D morphology, comparative genomics and developmental biology to prioritize gene edits when ancient DNA is scarce. Built over more than a year, it combines developmental data from chickens, quail, ducks and pigeons with genetic information and 3D skull measurements from more than 70 bird species. Colossal has only one dodo genome, compared with 100 woolly mammoth genomes because cold climates preserved mammoth DNA better than tropical conditions preserved dodo DNA. GenoMorph has identified approximately 2,300 candidate edits for dodo skull and facial traits.
CEO and co-founder Ben Lamm said laboratory validation comes next because predicted edits must still produce the required physical traits and cannot be presumed safe. Colossal developed lipid nanoparticles that deliver gene-editing tools directly into developing bird embryos, allowing tests without waiting through breeding cycles for sexual maturity. Its Nicobar pigeon colony, representing the dodo’s closest living relative, has reached 36 birds, and Colossal has created essential cells that become eggs and sperm. GenoMorph identifies targets rather than editing genes itself. XPRIZE founder and Colossal investor Peter Diamandis also launched NeoGenesis Capital to fund companies applying Colossal’s programmable biology platform across health, agriculture and conservation.
Positives
- Approximately 2,300 candidate DNA edits have been identified for dodo skull and facial morphology.
- More than 70 bird species contributed genetic information and 3D skull measurements to GenoMorph.
- Lipid nanoparticles can deliver gene-editing tools into embryos without waiting for birds to reach sexual maturity.
- Colossal’s Nicobar pigeon colony has reached 36 birds, supporting work with the dodo’s closest living relative.
- NeoGenesis Capital will fund programmable biology companies across health, agriculture and conservation.
Risks & concerns
- Only one dodo genome is available, compared with 100 genomes for Colossal’s woolly mammoth project.
- Tropical conditions preserved dodo DNA less effectively than cold climates preserved woolly mammoth DNA.
- GenoMorph’s approximately 2,300 predicted targets still require laboratory testing to confirm physical effects.
- Identifying an edit does not establish that introducing it into an animal would be safe.
- Producing cells that become eggs and sperm does not yet demonstrate creation of birds carrying dodo traits.